EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C20H26N3O5 |
| Net Charge | -1 |
| Average Mass | 388.444 |
| Monoisotopic Mass | 388.18779 |
| SMILES | O=C([O-])[C@H](CCc1ccccc1)[NH2+][C@H]1CCCN2CCC[C@@H](C(=O)[O-])N2C1=O |
| InChI | InChI=1S/C20H27N3O5/c24-18-15(8-4-12-22-13-5-9-17(20(27)28)23(18)22)21-16(19(25)26)11-10-14-6-2-1-3-7-14/h1-3,6-7,15-17,21H,4-5,8-13H2,(H,25,26)(H,27,28)/p-1/t15-,16-,17-/m0/s1 |
| InChIKey | UVAUYSRYXACKSC-ULQDDVLXSA-M |
| Roles Classification |
|---|
| Biological Roles: | EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor An EC 3.4.15.* (peptidyl-dipeptidase) inhibitor that interferes with the action of peptidyl-dipeptidase A (EC 3.4.15.1). |
| Applications: | EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor An EC 3.4.15.* (peptidyl-dipeptidase) inhibitor that interferes with the action of peptidyl-dipeptidase A (EC 3.4.15.1). antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| cilazaprilat(1-) (CHEBI:761025) has role antihypertensive agent (CHEBI:35674) |
| cilazaprilat(1-) (CHEBI:761025) has role cardiovascular drug (CHEBI:35554) |
| cilazaprilat(1-) (CHEBI:761025) has role drug metabolite (CHEBI:49103) |
| cilazaprilat(1-) (CHEBI:761025) has role EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor (CHEBI:35457) |
| cilazaprilat(1-) (CHEBI:761025) is a secondary ammonium ion (CHEBI:137419) |
| cilazaprilat(1-) (CHEBI:761025) is conjugate base of Cilazaprilat (CHEBI:81005) |
| UniProt Name | Source |
|---|---|
| cilazaprilat | UniProt |